Federal award
GEN-PROBE INCORPORATED
W81K0420F1113
Contract
Obligated and Ceiling
- Obligated (net)
- $19,492,975.08
- Ceiling (potential value, not spending)
- $19,492,975.08
- Current value
- $19,492,975.08
- Gross positive obligations
- $21,036,740.16
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- GEN-PROBE INCORPORATED · QNXWLAJDL4J3
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- GRIFOLS SA · G9PNB5K6E1U8
- Awarding agency
- Department of War · sub-agency 2100 · office W81K04
- Funding agency
- Department of War · sub-agency 2100
- Product or service (PSC)
- 6515 · MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES
- Industry (NAICS)
- 325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
- PIID
- W81K0420F1113
- Parent vehicle (IDV PIID)
- W81K0420D0007
- Award type code
- C
- Actions
- 9 · Apr 20, 2020 to Feb 2, 2022
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History9
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Feb 2, 2022 | FY2022 | P00008 | D | $98,956.64 | — |
| Jan 11, 2022 | FY2022 | P00007 | D | −$101,341.08 | — |
| Dec 9, 2020 | FY2021 | P00006 | M | $0.00 | — |
| Nov 25, 2020 | FY2021 | P00005 | D | $6,897,783.52 | — |
| Oct 28, 2020 | FY2021 | P00004 | D | $1,440,000.00 | — |
| Oct 26, 2020 | FY2021 | P00003 | D | −$1,440,000.00 | — |
| Sep 16, 2020 | FY2020 | P00002 | D | −$2,032.00 | — |
| Jul 22, 2020 | FY2020 | P00001 | D | −$392.00 | — |
| Apr 20, 2020 | FY2020 | 0 | — | $12,600,000.00 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.